Curve Biosciences

Mountain View, United States

Curve Biosciences is a biotechnology company that focuses on precision medicine for chronic diseases.

$40.0M raised

Oct 2025

Series A

Biotechnology Health Care Health Diagnostics

Top Investors

NZVCFirst Spark VenturesCivilization VenturesLife Extension VenturesLifeX Ventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Curve Biosciences

How much funding has Curve Biosciences raised?

Curve Biosciences has raised $40.0M in total funding. The most recent round was Series A. The last funding was announced in October 2025.

Who are Curve Biosciences's investors?

Curve Biosciences's investors include NZVC, First Spark Ventures, Civilization Ventures, Life Extension Ventures, LifeX Ventures.

Where is Curve Biosciences headquartered?

Curve Biosciences is headquartered in Mountain View, United States.

What does Curve Biosciences do?

Curve Biosciences is a biotechnology company that focuses on precision medicine for chronic diseases.

What stage is Curve Biosciences at?

Curve Biosciences is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 29, 2025.

MLA

"Curve Biosciences — Funding & Investors." VCBacked, October 29, 2025, https://www.vcbacked.co/company/curve-biosciences. Accessed June 17, 2026.

APA

VCBacked. (2025). Curve Biosciences — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/curve-biosciences

Wikipedia (cite web)

{{cite web |title=Curve Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/curve-biosciences |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 29, 2025.

Similar Companies in Biotechnology